Biblio Discovery — Demo Discovery Service

10 hasil untuk "G. K. Scadding"

Menampilkan 1–10 · 1,22 detik · RSS

  1. Artikel Jurnal

    ULANC - EUFOREA workshop 2024: bringing the concept of global airways to the frontline of medical care

    D. M. Conti; V. Backer; K. Aanaes dkk.

    Frontiers in Allergy, Vol. 6 · 2025 · Inggris · DOAJ Scopus

    The Upper and Lower Airways Northern European Consensus (ULANC) and the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized their first workshop in Copenhagen in January 2024. The aim of the “Primary care physicians and nurses with an interest in Global…

  2. Artikel Jurnal

    Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA

    T. Teeling; C. Djouder; H. Laurens dkk.

    Frontiers in Allergy, Vol. 5 · 2024 · Inggris · DOAJ Scopus

    Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a chronic inflammatory disease of the nose and paranasal sinus cavities that significantly affects well-being and social function, particularly in young adults and middle-aged populations. CRSwNP is a common health condition in the Western world…

  3. Artikel Jurnal

    European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned

    D. M. Conti; V. Backer; W. Fokkens dkk.

    Frontiers in Allergy, Vol. 5 · 2024 · Inggris · DOAJ Scopus

    The European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized the first European Biologic Training Course (EBTC) in Brussels on 1st March 2024. The aim of this hybrid EBTC including both face-to-face and web-based participation was to address the educational…

  4. Artikel Jurnal Teks lengkap

    EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023

    W.J. Fokkens; A-S Viskens; V. Backer dkk.

    Rhinology Journal · 2023 · Inggris · OpenAlex Scopus

    Severe chronic rhinosinusitis with nasal polyps (CRSwNP) is a debilitating disease with a significant impact on the quality of life (QoL). It is typically characterized by a type 2 inflammatory reaction and by comorbidities such as asthma, allergies and NSAID-Exacerbated Respiratory Disease…

  5. Artikel Jurnal

    Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024

    P. W. Hellings; D. M. Conti; X. Bertels dkk.

    Frontiers in Allergy, Vol. 6 · 2025 · Inggris · DOAJ Scopus

    In April 2024, the European Summit “Raising the bar in respiratory care” was organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) in the European Parliament and hosted by Members of the European Parliament Dorien Rookmaker and Mislav Kolakušić. The aim…

  6. Artikel Jurnal

    Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma

    G. K. Scadding; M. McDonald; V. Backer dkk.

    Frontiers in Allergy, Vol. 4 · 2024 · Inggris · DOAJ Scopus

    Asthma, which affects some 300 million people worldwide and caused 455,000 deaths in 2019, is a significant burden to suffers and to society. It is the most common chronic disease in children and represents one of the major causes for years lived with disability. Significant efforts are made by…

  7. Artikel Jurnal

    Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma

    G. K. Scadding; C. Gray; D. M. Conti dkk.

    Frontiers in Allergy, Vol. 5 · 2024 · Inggris · DOAJ Scopus

    The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health…

  8. Artikel Jurnal

    EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care

    P. W. Hellings; S. Lau; G. K. Scadding dkk.

    Frontiers in Allergy, Vol. 4 · 2023 · Inggris · DOAJ Scopus

    In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to…

  9. Artikel Jurnal

    EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care

    S. Lau; V. Backer; G. K. Scadding dkk.

    Frontiers in Allergy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    EUFOREA, the European Forum for Research and Education in Allergy and Airways diseases, is an international non-for-profit organisation of physicians, patients, and other stakeholders committed to the improvement of outcomes for patients suffering from chronic inflammatory respiratory conditions…

  10. Artikel Jurnal

    EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR

    G. K. Scadding; D. M. Conti; S. Scheire dkk.

    Frontiers in Allergy, Vol. 5 · 2025 · Inggris · DOAJ Scopus

    Allergic rhinitis (AR), the most prevalent immunological disease, affects approximately 400 million individuals globally and can significantly impact quality of life (QoL). Despite nearly 25 years of guidelines, AR remains largely under- diagnosed, suboptimally treated and poorly controlled. In the…